Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

USA - NASDAQ:MANH - US5627501092 - Common Stock

214.95 USD
+0.68 (+0.32%)
Last: 9/17/2025, 8:00:00 PM
214.95 USD
0 (0%)
After Hours: 9/17/2025, 8:00:00 PM
Fundamental Rating

7

MANH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. Both the health and profitability get an excellent rating, making MANH a very profitable company, without any liquidiy or solvency issues. MANH is quite expensive at the moment. It does show a decent growth rate. This makes MANH very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
In the past year MANH had a positive cash flow from operations.
Each year in the past 5 years MANH has been profitable.
In the past 5 years MANH always reported a positive cash flow from operatings.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of MANH (29.70%) is better than 97.50% of its industry peers.
MANH has a better Return On Equity (79.34%) than 97.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 65.54%, MANH belongs to the top of the industry, outperforming 99.64% of the companies in the same industry.
MANH had an Average Return On Invested Capital over the past 3 years of 55.23%. This is significantly above the industry average of 11.85%.
The last Return On Invested Capital (65.54%) for MANH is above the 3 year average (55.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 29.7%
ROE 79.34%
ROIC 65.54%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

MANH's Profit Margin of 20.91% is amongst the best of the industry. MANH outperforms 86.07% of its industry peers.
In the last couple of years the Profit Margin of MANH has grown nicely.
The Operating Margin of MANH (25.43%) is better than 89.64% of its industry peers.
MANH's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 56.28%, MANH is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.43%
PM (TTM) 20.91%
GM 56.28%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
MANH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MANH has less shares outstanding
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 20.05 indicates that MANH is not in any danger for bankruptcy at the moment.
MANH has a Altman-Z score of 20.05. This is amongst the best in the industry. MANH outperforms 92.86% of its industry peers.
MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.05
ROIC/WACC5.96
WACC11%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

MANH has a Current Ratio of 1.19. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MANH (1.19) is worse than 63.57% of its industry peers.
MANH has a Quick Ratio of 1.19. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.19, MANH is doing worse than 63.21% of the companies in the same industry.
The current and quick ratio evaluation for MANH is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

MANH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.02%, which is quite good.
The Earnings Per Share has been growing by 22.14% on average over the past years. This is a very strong growth
MANH shows a small growth in Revenue. In the last year, the Revenue has grown by 6.14%.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)17.02%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%11.02%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%2.68%

3.2 Future

Based on estimates for the next years, MANH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.76% on average per year.
The Revenue is expected to grow by 8.08% on average over the next years. This is quite good.
EPS Next Y3.7%
EPS Next 2Y6.28%
EPS Next 3Y10.13%
EPS Next 5Y17.76%
Revenue Next Year3.4%
Revenue Next 2Y5.02%
Revenue Next 3Y6.4%
Revenue Next 5Y8.08%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

MANH is valuated quite expensively with a Price/Earnings ratio of 42.82.
MANH's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.20. MANH is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 40.23, which means the current valuation is very expensive for MANH.
MANH's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. MANH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 42.82
Fwd PE 40.23
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MANH is valued a bit cheaper than the industry average as 65.36% of the companies are valued more expensively.
MANH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MANH is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.3
EV/EBITDA 46.36
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)11.58
PEG (5Y)1.93
EPS Next 2Y6.28%
EPS Next 3Y10.13%

0

5. Dividend

5.1 Amount

No dividends for MANH!.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (9/17/2025, 8:00:00 PM)

After market: 214.95 0 (0%)

214.95

+0.68 (+0.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners101.52%
Inst Owner Change0.72%
Ins Owners1.23%
Ins Owner Change-2.58%
Market Cap13.00B
Analysts78.82
Price Target233.25 (8.51%)
Short Float %2.66%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.8%
Min EPS beat(2)13.66%
Max EPS beat(2)13.93%
EPS beat(4)4
Avg EPS beat(4)15.06%
Min EPS beat(4)8.28%
Max EPS beat(4)24.36%
EPS beat(8)8
Avg EPS beat(8)19.75%
EPS beat(12)12
Avg EPS beat(12)22.74%
EPS beat(16)16
Avg EPS beat(16)23.8%
Revenue beat(2)2
Avg Revenue beat(2)0.85%
Min Revenue beat(2)0.44%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.26%
Revenue beat(8)6
Avg Revenue beat(8)1.49%
Revenue beat(12)10
Avg Revenue beat(12)2.96%
Revenue beat(16)14
Avg Revenue beat(16)3%
PT rev (1m)0%
PT rev (3m)8.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.06%
EPS NY rev (1m)4.52%
EPS NY rev (3m)4.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE 42.82
Fwd PE 40.23
P/S 12.29
P/FCF 42.3
P/OCF 41.09
P/B 46.63
P/tB 60.03
EV/EBITDA 46.36
EPS(TTM)5.02
EY2.34%
EPS(NY)5.34
Fwd EY2.49%
FCF(TTM)5.08
FCFY2.36%
OCF(TTM)5.23
OCFY2.43%
SpS17.49
BVpS4.61
TBVpS3.58
PEG (NY)11.58
PEG (5Y)1.93
Profitability
Industry RankSector Rank
ROA 29.7%
ROE 79.34%
ROCE 79.69%
ROIC 65.54%
ROICexc 206.87%
ROICexgc 495.06%
OM 25.43%
PM (TTM) 20.91%
GM 56.28%
FCFM 29.05%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 139.79%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 114.85%
Profit Quality 138.95%
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 20.05
F-Score7
WACC11%
ROIC/WACC5.96
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%11.02%
EPS Next Y3.7%
EPS Next 2Y6.28%
EPS Next 3Y10.13%
EPS Next 5Y17.76%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%2.68%
Revenue Next Year3.4%
Revenue Next 2Y5.02%
Revenue Next 3Y6.4%
Revenue Next 5Y8.08%
EBIT growth 1Y12.98%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year8.29%
EBIT Next 3Y8.86%
EBIT Next 5Y11.24%
FCF growth 1Y63.2%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y62.71%
OCF growth 3Y16.79%
OCF growth 5Y14.96%